call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
2ข้อเสนอควบคุมค่ายาcsmbs131109
1. F F FF F F
..
F
13 2552
F F F F F / F
F F F F
F F F F F F
F F F F F
F F F F F F (Diagnosis Related
Group: DRG) F F F F F F
F F F F F F F
(Fee-for-service) F F F
F F F F F
F F F F
1 F F F . . 2545
- 2552
: F 2552 31
2. 2
F F F F F FF F . . 2547
F F F FF F F
DRG F F F F FF F
F F F F F F F
F F F F FF DRG
2 F F F F 2532 - 2552
: F 2552 F F1 2551 31 2552
F F F F F F F (F 83) F
F 900 F F 34 F F F F
F F F F 35 F F F FF F F F 60
(~20,000 F ) F F F
F F F F F F F F F
F F F F F F
F F F
F F F FF F F
F FF F F
F F F F F FF F F
3. 3
1) F F F F
F F F FF F F
F ( F . .2550 F F F
F F F F F F ) F F F F
F F
2) F F F F F F F
F F F F F
F F F F F F F
F F F F F F F
F F F F F F
F F F FF F
3) F F F F F F
F FF F F F F F
F (Original Brand) F F F F F
F F F F F F F
F F F F
F
4) F F
(1) . . 2523 F F F
FF F F F
F F F F F F FF (2) F F
F F F
F F F
F (3)
F F
F F F F
F
1) F F
F F F
F
4. 4
2) FF ( .)
( .) ( .)
F F F F
F . . 2553 - 2555 F F F F
F F F F FF F (1)
F F F F F F
F 34 F (2) F F
F (3) F
F 34 F F FF F
F F F FF F (4) F FF
F F F F F F F F FF (acaedemic detailling)
F F F F F F F F F (5) F F FF F
F F F F F F F F F
( F DRG) F (Differential capitation) F F
(point system) F
F F F F F
F F F F F F
F F F FF
F FF
3) 3 2552
F F F F
34 F F F F F 30
F F F F F F
F FF F 12 2552
. F F F F
F
3.1) F 2542 F F
F FF F F F F F F F
F F F F F
F F F F F
F F F
5. 5
3.2) F F FF F (1) F F
original manufacturer F generic equivalent
F F (2) F F
F F F F F
F F therapeutic equivalent
F F F F 10
. .2552 F 6 2552 F F F
31 F 34 F 1
1 F F F
31 F
. F . . .
( F) (N=7) (N=16) (N=8) (N=31)
( ) 6,914,378 5,675,890 4,058,066 16,648,334
- ( ) 3,107,884 1,727,876 1,781,563 6,617,323
(%) 45% 30% 44% 40%
F ( ) 8,524,258,820 3,323,777,098 3,399,923,178 15,247,959,096
F ( ) 5,580,080,654 2,105,324,655 2,355,071,378 10,040,476,687
F (%) 65% 63% 69% 66%
31 F 16.6 F
F F 40 . F . F
15,247.95 F F F F 66
F F F F F F
F FF F F F F
F F F F F
F F F F F F F F F 2
6. 6
2 F F F . 27 F F
F F F F
F F
F (F (x1,000 F F
(x1,000 ) ) ) (F ) F
16,648 15,248 6,617 10,040
1. F
Anti-ulcerant /variceal bleeding 646 715 261 666 599 3.9%
2. F F F F
NSAIDs/ anti-osteoarthritis 891 1,022 671 993 415 2.7%
3. F
Antilipidemia 855 1,467 377 1,266 1,009 6.6%
4. F F
F
Angiotensin converting
enzyme (ACE) inhibitors 263 125 74 99 87 0.6%
5. F
Angiotensin-II receptor blockers
(ARBs) 327 622 280 558 158 1.0%
6. F
Antiplatelets 475 468 24 37 376 2.5%
7. F F Glucosamine 442 442 2.9%
8. Drug
affecting bone metabolism 190 738 187 712 712 4.7%
9. F Anticancers 129 1,441 21 647 647 4.2%
1- 9 4,614 7,679 2,057 5,488 4,851 31.8%
F F 3, 7, 8
6 F F
F (Plavix) F (Colpidogrel) F 5
4) F . F
F F 2 2552 F
F F F F F F F F
F F FF 2 F
7. 7
(1) F F F (Negative drug
lists) F F F F F F
Glucosamine F
F F F (Osteoarthritis) F F
F F F 31 F F 442 F F
2.9 F FF 31 F
(2) F F F F F F F
F F F F F F F F F F F
F F F F F F F F F
F F F F F F F
F F F F F F F
F F F F F F F F
F F F F F 31 F F 1,467 F F
1,265 F F F
1,009 F F 6.6 F FF 31 F
(3) F F F (Bone
metabolism) F F F F F F F F
F F F
F F F F
F F F F F F (Bone
metabolism) F F F F
1
F F F F F F F
F F F F F F F F
F F F
F F 31 F F 738 F F 712 F
F F F F F F F F 712 F
F 4.7 F 31 F
1
F F F F
. F
8. 8
F F F F F
F FF F F F 2,162 F F 14 F
F 31 F
F
F
F F F FF F
F F F F F
F
1. F F
F FF F 2553 F 4 (1) - (3) F
F 3 F
2. F F F
F F F F
F F
3. F F F F
F F F F F
F F F F F F
F F FF